Zealand Pharma valuation

ZEAL · Nasdaq Copenhagen · DKK

Compare Zealand Pharma
kr 229.60Change from previous close: −4.25%Absolute change: −kr 10.20

Close · November 17, 2026

Valuation

The P/E ratio is 5.49. The average price target of 12 analysts is kr 386.08.

Data as of November 16, 2026

Zealand Pharma compared with similar companies

Zealand Pharma's P/E (trailing 12 months): 5.49, −67% against the median of a group of 9 similar companies (16.6).

Zealand Pharma's metrics compared with similar companies
MetricZealand PharmaMedian25th–75th percentileBand
P/E (trailing 12 months)5.4916.65.49 – 38.0Middle
Forward P/E33.433.718.4 – 53.7Middle
EV/EBITDA1.1514.59.80 – 24.9Low
Price/book0.943.891.74 – 8.03Low
Price/sales3.493.642.74 – 11.5Middle
Gross margin100.0%87.2%59.2% – 93.2%High
Operating margin59.0%21.3%9.8% – 47.5%High
Net margin67.2%21.2%8.4% – 45.7%High
ROE19.1%19.1%7.7% – 27.7%Middle
Debt/equity0.030.030.02 – 0.34Middle

Group: the stock and up to 10 companies in the same industry (with fewer than 5, related industries too), same region first, with a similar size. Band: low = the lowest quarter of values in the group, middle = 25th to 75th percentile, high = the highest quarter. Negative multiples and multiples above 500 are excluded; a comparison needs at least 5 values. The group is recalculated nightly.

TickerLandia analysisHow it is calculated

Companies in the group: same industry, similar size

Other metrics

Valuation multiples

Market cap
kr 16.05B
Enterprise value
kr 3.15B
EV/revenue
0.69

Profitability and growth

ROA
9.4%
ROIC
8.4%
Revenue growth (year over year)
-92.0%
Earnings growth (year over year)
-47.6%

Financial health

Total cash
kr 13.51B
Total debt
kr 484M
Current ratio
10.5
Quick ratio
10.4
Altman Z-Score
8.84
Piotroski F-Score
3.00

Dividends

Dividend yield
0.0%
Payout ratio
0.0%

Analysts and estimates

Average price target
kr 386.08
Median price target
kr 375.00
High price target
kr 550.00
Low price target
kr 280.00
Analysts with a price target
12
Consensus
Buy
Forward EPS
kr 7.24
EPS estimate, current year
kr 33.04

Shares and trading

Beta
0.47
Average volume
393.6K
Shares outstanding
66.33M
Float
57.03M
Institutional ownership
38.5%
Insider ownership
0.5%